Biogen Idec Announces Restructuring with ALS Emerging to Forefront

Biogen has issued a press release outlining its new strategic focus in neurology with particular mention of its expanding ALS therapeutic program. Biogen also intends to concentrate its development and manufacturing efforts on therapeutics that leverages its expertise in biologics.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail